Hair restoration surgery: Challenges and solutions

Clinical, Cosmetic and Investigational Dermatology

Volumn 8, Issue , 2015, Pages 361-370

  Rose, Paul T ^a  

^a Hair Transplant Institute of Miami   (United States)

Author keywords

Alopecia; Hair loss; Hair transplant; Surgical procedure

Indexed keywords

ANDROSTANOLONE; BIMATOPROST; DUTASTERIDE; ELASTIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; FINASTERIDE; INTERLEUKIN 8; LAMININ; MINOXIDIL; PROSTAGLANDIN; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; DERMATOLOGICAL EQUIPMENT; DERMATOLOGICAL PROCEDURE; DONOR; EXTRACELLULAR MATRIX; FOLLICULAR ISOLATION TECHNIQUE; FOLLICULAR UNIT EXTRACTION; GRAFT PRESERVATION; GRAFT SURVIVAL; HAIR GROWTH; HAIR LOSS; HAIR TRANSPLANTATION; HUMAN; LOW LEVEL LASER THERAPY; MALE TYPE ALOPECIA; MESENCHYMAL STEM CELL; NONHUMAN; PSYCHOLOGICAL WELL BEING; ROBOTICS; SCAR FORMATION; SELF ESTEEM; SKIN DISEASE; SKIN INJURY; SURGICAL APPROACH; SURGICAL TECHNIQUE; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; WOUND HEALING;

EID: 84938281876     PISSN: None     EISSN: 11787015     Source Type: Journal    
DOI: 10.2147/CCID.S53980     Document Type: Article

References (79)

1. Okuda S. The study of clinical experiments of hair transplantation. Jpn J Dermatol Urol. 1939:46:135.
2. Orentreich N. Autografts in alopecias and other selected dermatological conditions. Annals of the New York Academy of Sciences. 1959; 83: 463-479.
3. Unger WP. The History of Hair Transplantation. 4th ed. Unger WP, Shapiro R, editors. New York: Marcel Dekker; 2004.
4. Headington JT. Transverse microscopic anatomy of the human scalp. A basis for morphometric approach to disorders of the hair follicle. Arch Dermatol. 1984:120:449-456.
5. Bernstein R, Rassman W, Szaniawski W, Halperin A. Follicular unit transplantation. Int J Aesth Restor Surd. 1995;3:119-132.
6. Limmer BL. Elliptical strip stereoscopically assisted micrografting as an approach to further refinement in hair transplantation. J Dermatol Surg Oncol. 1994;28:789-793.
7. Rose P. Considerations in establishing a natural hairline. Int J Cosmet Surg. 1998;6:24-26.
8. Rose PT, Parsley WP. The science of hair line design. In: Haber RS, Stough DB, editors. Procedures in Cosmetic Dermatology. Hair Transplantation. Philadelphia: Elsevier Saunders; 2006:55-72.
9. Shapiro R, Shapiro P. Hairline design and frontal hairline restoration. Facial Plast Surg Clin North Am. 2013;21:351-362.
10. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68:1359-1365.
11. Rose PT. The trichophytic closure. In: Unger WP, Shapiro R, Unger R, editors. Hair Transplantation. 5th ed. New York: Informa Healthcare Publishing; 2011:261-279.
12. Frechet P. Minimal scars for scalp surgery. Dermatol Surg. 2007;33(1): 45-55.
13. Marzola M. Trichophytic closure of the donor area. Hair Transplant Forum Int.2005;15(4):113-116.
14. Puig C. Controlled dissection for trichophytic closure with a ledge knife. Hair Transplant Forum Int. 2008:18(6):211.
15. Kim DY. Planing off the inferior edge in the Frechet & Rose trichophytic closures. Hair Transplant Forum Int. 2008;18(6):211.
16. Reese R. Regenerative Medicine Part 2: Use of Platelet Rich Plasma in Hair, Hair Transplant 360, Volume 3, Lam S editor, New Delhi, Jaypee Brothers Publishing, 2014:565-573.
17. Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83(1):1-9.
18. Hitzig GS. Regenerative medicine part 1: usage of porcine extracellular matrix in hair loss prevention, hair restoration surgery and donor scar revision. In: Lam S, editor. Hair Transplant 360, Volume 3. New Delhi: Jaypee Brothers Publishing; 2014:553-564.
19. Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng. 2006;12:519-526.
20. Cooley JE. Use of porcine bladder matrix in hair restoration surgery applications. Hair Transplant Forum Int. 2011;3:70-72.
21. Puig C. Use of PRP and Dermal Matrix. Presented at: Annual Meeting of the American Academy of Cosmetic Surgery; January 14; 2015; New Orleans, LA. (Lecture)
22. Rassman WR, Bernstein RM, McClellan R, Jones R, Worton E, Uyttendaele H. Follicular unit extraction: minimally invasive surgery for hair transplantation. Dermatol Surg. 2002;28:720-728.
23. Rose PT. Approaches to FIT. Presented at: International Society of Hair Restoration Surgery, Annual Meeting; August 18-25, 2005; Sydney, Australia. (Lecture)
24. Rose PT. The use of a suction apparatus to improve healing of FUE wound sites. Presented at: International Society of Hair Restoration Surgery, Annual Meeting; October 22-26, 2013; San Francisco, CA. (Lecture)
25. Rassman WR, Pak JP, Kim J. Scalp micropigmentation: a useful treatment for hair loss. Facial Plast Surg Clin North Am. 2013;21: 497-503.
26. Rose PT. Internal angle of hair growth versus exit angle as it relates to FUE/FIT. Presented at: International Society of Hair Restoration Surgery Annual Meeting; 2010; Boston, MA. (Lecture)
27. Rose PT, Nusbaum B. Robotic hair restoration. Dermatol Clin. 2014;32:97-107.
28. Harris JA. Robotic assisted follicular unit extraction for hair restoration: case reports. Cosmet Dermatol. 2012;25(6):284-287.
29. Wesley C. Endoscopic follicular extraction. Presented at: American Academy of Cosmetic Surgery Annual Meeting; January 14-17, 2015; New Orleans, LA. (Lecture)
30. Beehner ML. Graft survival, graft growth, and healing studies. In: Unger WP, Shapiro R, editors. Hair Transplantation. 4th ed. New York: Marcel Dekker; 2004:281-284.
31. Limmer BL. Micrograft survival. In: Stough DB, editor. Hair Replacement Surgical and Medical. St Louis: Mosby; 1996:147-149.
32. Parsley WP, Perez-Mesa D. Review of factors affecting the growth and survival of follicular grafts. J Cutan Aesthet Surg. 2010;3(2):69-75.
33. Cooley JE. Ischemia-reperfusion injury and graft storage solutions. Hair Transplant Forum Int. 2004;14:121-139.
34. Cooley JE. Optimal graft growth. Facial Plast Surg Clin North Am. 2013;21:449-455.
35. Krugluger W, Moser K, Moser C, Laciak K, Hugeneck J. Enhancement of in vitro hair shaft elongation in follicles stored in buffers that prevent follicle cell apoptosis. Dermatol Surg. 2004;30:1-5.
36. Cooley JE. Bio-Enhanced Hair Restoration. Hair transplant Forum International. 2014;24(4)121,128-130.
37. Beehner M. 96-hour study of FU graft "out-of-body" survival comparing saline to hypothermosol/ATP solution. Hair Transplant Forum Int. 2011;21(2):33-37.
38. Keene S, Goren A. Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics. Dermatol Ther. 2011;24: 296-300.
39. Drake L, Hordinsky M, Fiedler V, et al. The effect of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41:550-554.
40. Kaufman KD, Olson EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39: 578-589.
41. Nusbaum AG, Rose PT, Nusbaum BP. Nonsurgical therapy for hair loss. Facial Plast Surg Clin North Am. 2013;21:335-342.
42. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol. 1999;41(5 Pt 1):717-721.
43. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349: 215-224.
44. Andriole GL, Bostwick DG, Brawley OW, et al; the REDUCE Study Group. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362:1192-1202.
45. Zappacosta AR. Reversal of baldness in patient receiving minoxidil for hypertension. N Engl J Med. 1980;303:1480-1481.
46. Shorter F, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP sensitive potassium channels only one of which is switched by minoxidil. FASEB J. 2008;22(6):1725-1736.
47. Blume-Peytavi U, Lönnfors S, Hillman K, Garcia Bartels N. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol. 2012;66(5):794-800.
48. Mester E, Szende B, Gärtner P. [The effect of laser beams on the growth of hair in mice]. Radiobiol Radiother (Berl). 1968;9:621-626. German.
49. Mester E, Spiry T, Szende B, Tota JG. Effect of laser rays on wound healing. Am J Surg. 1971;122:532-535.
50. Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40(2):516-533.
51. Hamblin MR, Demidova TN. Mechanisms of low level light therapy. SPIE Proc. 2006;6140:1-12.
52. Leavitt M, Charles G, Heyman E, Michaels D. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283-292.
53. Munck A, Gavazzoni MF, Trueb RM. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. Int J Trichology. 2014;6:(2)45-49.
54. Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15:115-127.
55. Kim H, Choi JW, Kim JY, Shin JW, Lee SJ, Huh CH. Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial. Dermatol Surg. 2013; 39(8):1177-1183.
56. Hamblin M. Mechanism of Laser-induced Hair Regrowth. Boston: Wellman Center for Photomedicine; 2006. Available from http://www.photobiology.info/Hamblin.html: Biomed.laser.org. Accessed March 2, 2015.
57. Keene S. The science of light biostimulation and low-level laser therapy. Hair Transplant Forum Int. 2014;24;(6):201-209.
58. Garza LA, Liu Y, Yang Z, et al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med. 2012;4(126):126ra134.
59. Magro CM, Rossi A, Poe J, Manhas-Bhutani S, Sadick N. The role of inflammation and immunity in the pathogenesis of androgenetic alopecia. J Drugs Dermatol. 2011;10(12):1404-1411.
60. Uebel C. A new advance in baldness surgery with the platelet derived growth factor. Hair Transplant Forum Int. 2005;15(3):770-777.
61. Greco J, Brandt R. Preliminary experience and extended applications for the use of autologous platelet-rich plasma in hair transplantation surgery. Hair Transplant Forum Int. 2007;17(4):131-132.
62. Li ZJ, Choi HI, Choi DK, et al. Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg. 2012;38:1040-1046.
63. Yanko K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest. 2001;107(4):409-417.
64. Takikawa M, Nakamura S, Nakamura S, et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth, Dermatol Surg. 2011;37(12):1721-1729.
65. Miao Y, Sun YB, Sun XJ, Du BJ, Jiang JD, Hu ZQ. Promotional effect of platelet-rich plasma on hair follicle reconstitution in vivo. Dermatol Surg. 2013;39:1868-1876.
66. Lyubimova A, Garber JJ, Upadhyay G, et al. Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice. J Clin Invest. 2010;120(2):446-456.
67. Woo WM, Zhen HH, Oro AE. Shh maintains dermal papilla identity and hair morphogenesis via a Noggin-Shh regulatory loop. Genes Dev. 2012;26(11):1235-1246.
68. Zheng Y, Du X, Wang W, Boucher M, Parimoo S, Stenn K. Organogenesis from dissociated cells: generation of mature cycling hair follicles from skin-derived cells. J Invest Dermatol. 2005;124(5): 867-876.
69. Marshall BT, Ingraham CA, Wu X, Washenik K. Future horizons in hair restoration. Facial Plast Surg Clin North Am. 2013;21:521-528.
70. Higgins CA, Christiano A. Regenerative medicine and hair loss: how hair follicle culture has advanced our understanding of treatment options for androgenetic alopecia. Regen Med. 2014;9(1):101-111.
71. Jahoda CA, Horne KA, Oliver RF. Induction of hair growth by implantation of cultured dermal papilla cells. Nature. 1984;311(5986): 560-562.
72. Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CA. Transgender induction of hair follicles. Nature. 1999; 402(6757):33-34.
73. Kobayashi K, Nishimura E. Ectopic growth of mouse whiskers from implanted lengths of plucked vibrissa follicles. J Invest Dermatol. 1989;92:278-282.
74. Li S, Thangapazham RL, Wang JA, et al. Human TSC-2 null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis. Nat Commun. 2011;2:235.
75. Gnedeva K, Vorotelyak E, Cimadamore F, et al. Derivation of hair-inducing cell from human pluripotent stem cells. PLoS One. 2015;10: e0116892.
76. Koźlik M, Wójcicki P. The use of stem cells in plastic and reconstructive surgery. Adv Clin Exp Med. 2014;23:1011-1017.
77. Festa E, Fretz J, Berry R, et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell. 2011;146:761-771.
78. Comella, K. US Stem Cell Training Course, May 1-3, 2015, Sunrise, Florida, USA.
79. Toyoshima KE, Asakawa K, Ishibashi N, et al. Fully functional hair follicle regeneration through the rearrangement of stem cells and their niches. Nat Commun. 2012;3:784.